Apply to the MRC βGap Fundβ for single-step support in developing a new or repurposed medicine, medical device, diagnostic, or other medical product.
Projects must target a high-risk development step backed by prior funding, generating critical data to de-risk onward progression or determine failure.
The βGap Fundβ strategically bridges the smaller Impact Acceleration Account (IAA) and the larger Developmental Pathway Funding Scheme (DPFS).
Applicants must be based at a Medical Research Council (MRC) eligible research organisation.